ClinicalTrials.gg
CompletedNCT07245030Updated Oct 27, 2026

Effectiveness of Virtual Reality vs Show-Do Technique on Dental Anxiety in Children With Hearing Impairment

An interventional study of virtual reality distraction and show-do technique in Dental Anxiety of Hearing Impairment, sponsored by October University for Modern Sciences and Arts. Completed at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Primary conditionBehaviorRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Behavior
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's title name Behavior.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by October University for Modern Sciences and Arts · Not applicable, Interventional, and Prevention

Updated Oct 27, 2026Now CompletedStart date moved+5 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This randomized controlled clinical trial aims to compare the effectiveness of virtual reality (VR) eyewear used as a distraction method in combination with the Show-Do (SD) technique versus the traditional Show-Do technique alone in managing dental anxiety and improving behavioral responses among Egyptian children with different levels of hearing impairment during a dental prophylaxis procedure. The study will evaluate dental anxiety using pulse rate and the PJS-Pictorial Scale, while behavior will be assessed using the Frankl Behavior Rating Scale. The trial seeks to provide evidence-based guidance on the implementation of VR technology as an adjunctive non-pharmacological tool for children with communication barriers in pediatric dentistry.

Read the detailed description

Dental anxiety is a common barrier to effective dental care in pediatric patients, particularly in children with special health care needs such as hearing impairment. Communication limitations can increase anxiety and reduce cooperation, complicating dental treatment delivery. Traditional non-pharmacological techniques such as the Show-Do (SD) method are widely used to reduce anxiety by familiarizing children with dental procedures through demonstration and gradual exposure. However, their effectiveness may be limited in children with hearing impairments, who may not fully understand auditory or verbal explanations.

Virtual reality (VR) eyewear represents an innovative behavioral management tool that immerses the child in an interactive and engaging virtual environment, thereby diverting attention away from the dental procedure and reducing anxiety. Evidence from recent systematic reviews indicates that VR interventions can significantly decrease pain perception and anxiety in pediatric medical and dental settings, yet studies specifically targeting children with hearing impairment remain scarce.

This randomized controlled trial will be conducted at the Pediatric Dentistry Department, Faculty of Dentistry, MSA University. Participants will include children with varying levels of hearing impairment requiring dental prophylaxis. Eligible participants will be randomly assigned in a 1:1 ratio to either the control group (Show-Do technique only) or the intervention group (Show-Do technique combined with VR eyewear). Dental anxiety will be measured objectively using pulse oximetry and subjectively using the PJS-Pictorial Scale, while behavior will be assessed using the Frankl Behavior Rating Scale.

The study is designed to generate clinical evidence regarding the efficacy of integrating VR eyewear with conventional behavioral management methods for children with communication challenges. The results are expected to contribute to the development of inclusive, non-pharmacological strategies to manage dental anxiety and improve cooperation among pediatric patients with hearing impairments, ultimately enhancing patient-centered care in pediatric dentistry.

02

Conditions studied

  • Dental Anxiety of Hearing Impairment

Browse trials for

Keywords

  • dental prophylaxis procedure
  • scaling
  • polishing
  • oral hygiene instructions
  • virtual reality
  • Anxiety
  • behavioral
  • hearing impairment
03

In context

Behavior Reclassified

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 54 is below the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

October University for Modern Sciences and Arts is the lead sponsor of 51 studies on the registry; 19 are open to participants now.

Compared within Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children with moderate to severe or profound hearing loss.
  2. Children require dental prophylaxis.
  3. Apparently, Health Children.

Exclusion criteria

Exclusion Criteria:

  1. Children with severe cognitive impairment or developmental disorders.
  2. Children who are unable or unwilling to cooperate with the study protocol or assessment.
  3. Children with complicated systemic diseases.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Children with different levels of hearing impairment, using Show-Do Technique in combined with VR ey

    A- Show-Do Technique: Description: This technique will be integrated with the VR eyewear intervention to enhance understanding and comfort. The show-do technique involves: * Show: The child will be shown the dental tools and explain their purpose, possibly using visual aids or models. * Do: The procedure will be Performed as explained with continuous reassurance and support. B- Virtual Reality Component: Participants in this group will experience a virtual reality (VR) eyewear in an environment designed to distract them during dental prophylaxis procedure. The VR content will be age-appropriate and engaging, and featuring interactive (e.g., Fun animations, and Cartoons). Implementation: Before the dental treatment and after the implementation with show-do, children will be fitted with VR eyewear, where the aim is to immerse the child in the VR experience to reduce their focus on the dental treatment. Duration: • The VR eyewear experience will last for the duration of t

    Device: virtual reality distraction

  • Active comparator
    Children with different levels of hearing impairment, using Show-Do Technique:

    Participants in this group will receive the standard show-do technique without the VR eyewear distraction. The same steps (Show, Do) will be employed to prepare the child for the dental procedure, but without the use of VR technology.

    Behavioral: show-do technique

Interventions

  • Devicevirtual reality distraction

    children wear virtual reality glasses during dental prophylaxis procedure to reduce dental anxiety and enhance patient's behavior.

  • Behavioralshow-do technique

    conventional behavioral technique where the dentist shows and then perform the procedure to reduce anxiety and build cooperation.

06

What researchers measure

Primary outcomes

  1. anxiety level (objective)

    tool: pulse oximeter unit: beats per minute

    Time frame: baseline (5 minutes before session), during treatment (real-time), and immediately post-treatment (within 5 minutes)

Secondary outcomes

  1. anxiety level (subjective)

    tool: Pictorial Judgement Scale for Anxiety Assessment (PJS-pictorial scale) unit: score 1-5, (1: means very happy, 5: means very anxious.)

    Time frame: immediately before treatment (baseline), during treatment (real-time), and immediately after treatment (post-procedure)

  2. behavior assessment

    tool: Frankel rating scale unit: score 1-4 (1: means definitely negative and 4: means definitely positive)

    Time frame: immediately before treatment (baseline), during treatment (real-time), and immediately after treatment (post-procedure)

07

Study locations

1 site
  • October University for Modern Sciences and Arts
    Giza, Giza Governorate 12451, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 26, 2026
Sites
1 site removed
Show 1 removed
  • October University for Modern Sciences and Arts · Giza, Egypt
Oct 26, 2026
Start date
Oct 20, 2026→Dec 20, 2025
moved 2 times, Oct 26, 2026 – Oct 27, 2026
Primary completion
Nov 1, 2026→Jul 29, 2026 (actual)
Oct 26, 2026
Study completion
Dec 1, 2026→Jul 29, 2026 (actual)
Oct 26, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedChildren with moderate to severe Hearing impairmentor profound hearing loss.
Oct 26, 2026
Show all 2 updates
  1. Oct 27, 2026
    Start date May 16, 2026→Dec 20, 2025
  2. Oct 26, 2026
    Recruiting→Completed
    1 site removed
    Show 1 removed
    • October University for Modern Sciences and Arts · Giza, Egypt
    Start date Oct 20, 2026→May 16, 2026 (now actual)
    Primary completion Nov 1, 2026→Jul 29, 2026 (now actual)
    Study completion Dec 1, 2026→Jul 29, 2026 (now actual)
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedChildren with moderate to severe Hearing impairmentor profound hearing loss.
    + 3 other changes: verification date, design details and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07245030
Lead sponsor
October University for Modern Sciences and Arts
Responsible party
Tamara Saleh (general practitioner, October University for Modern Sciences and Arts) — Principal investigator
First posted
Nov 24, 2025
Start date
Dec 20, 2025
Primary completion
Jul 29, 2026
Completion
Jul 29, 2026
Last update
Oct 27, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion